First Horizon Advisors’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-863
| Closed | -$24.9K | – | 2278 |
|
|
2024
Q3 | $24.9K | Sell |
863
-33
| -4% | -$952 | ﹤0.01% | 1278 |
|
|
2024
Q2 | $34.4K | Buy |
896
+185
| +26% | +$7.1K | ﹤0.01% | 1085 |
|
|
2024
Q1 | $41.8K | Buy |
711
+39
| +6% | +$2.29K | ﹤0.01% | 1034 |
|
|
2023
Q4 | $40.2K | Buy |
672
+23
| +4% | +$1.38K | ﹤0.01% | 1042 |
|
|
2023
Q3 | $24.7K | Buy |
649
+265
| +69% | +$10.1K | ﹤0.01% | 1158 |
|
|
2023
Q2 | $35K | Buy |
384
+29
| +8% | +$2.64K | ﹤0.01% | 1040 |
|
|
2023
Q1 | $23.4K | Buy |
+355
| New | +$23.4K | ﹤0.01% | 1205 |
|
|
2021
Q4 | – | Sell |
-4
| Closed | – | – | 2249 |
|
|
2021
Q3 | $0 | Buy |
+4
| New | – | ﹤0.01% | 2271 |
|